Statistics
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
| Views | |
|---|---|
| Evaluating ... | 1199 |
Total Visits Per Month
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Evaluating ... | 28 | 8 | 12 | 6 | 7 | 9 | 7 |
File Visits
| Views | |
|---|---|
| 21VmhogDXFlrE.pdf | 567 |